Talk:Deupsilocin
Add topicAppearance
Latest comment: 1 year ago by MeridianQuill in topic Remove unsupported patent claim
| This is the talk page for discussing improvements to the Deupsilocin article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
| This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
Remove unsupported patent claim
[edit]The statement “This deuterated analogue of psilocin was patented in 2021 by Lennham Pharmaceuticals” is not supported by the cited patent US 11000534, which claims compositions of deuterated psilocybin. I propose the line in question be deleted due to being factually incorrect.
Disclosure: I am an employee of Cybin and therefore have a conflict of interest. I’m requesting this change for independent review and will not edit the article directly. MeridianQuill (talk) 15:36, 27 August 2025 (UTC)
